{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:52:36Z","timestamp":1760575956642,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/clon.2001.9290","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T15:41:36Z","timestamp":1067355696000},"page":"361-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of Malignant Phaeochromocytoma: A Retrospective Review of the use of MIBG and Chemotherapy in the West Midlands"],"prefix":"10.1053","volume":"13","author":[{"given":"A.","family":"Hartley","sequence":"first","affiliation":[]},{"given":"D.","family":"Spooner","sequence":"additional","affiliation":[]},{"given":"A.M.","family":"Brunt","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1053\/clon.2001.9290_RF1","first-page":"713A","article-title":"Malignant potential of phaeochromocytoma: implications for follow up","volume":"34","author":"Bierwaltes","year":"1986","journal-title":"Clin Res"},{"key":"10.1053\/clon.2001.9290_RF2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF03348026","article-title":"The treatment of malignant phaeochromocytoma with 131I MIBG: a comprehensive review of 116 reported patients","volume":"20","author":"Loh","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/clon.2001.9290_RF3","first-page":"277","article-title":"Results of I-131 MIBG treatment in metastatic malignant phaeochromocytoma","volume":"35","author":"Bestagno","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1053\/clon.2001.9290_RF4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/clon.2001.9290_RF5","first-page":"269","article-title":"Radiopharmaceutical therapy with I-131 MIBG: results from ten years' experience","volume":"35","author":"Shapiro","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1053\/clon.2001.9290_RF6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","article-title":"Malignant phaeochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine and dacarbazine","volume":"109","author":"Averbuch","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/clon.2001.9290_RF7","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2169\/naika.85.2078","article-title":"Case of malignant phaeochromocytoma with successful control of systemic metastasis with CVD chemotherapy","volume":"85","author":"Minami","year":"1996","journal-title":"J Jpn Soc Int Med"},{"key":"10.1053\/clon.2001.9290_RF8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000023190","article-title":"Three cases of malignant phaeochromocytoma treated with cyclophosphamide, vincristine and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia","volume":"49","author":"Tada","year":"1998","journal-title":"Hormone Res"},{"key":"10.1053\/clon.2001.9290_RF9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1507\/endocrj.43.279","article-title":"Two cases of Management of Malignant Phaeochromocytoma 365 malignant phaeochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy","volume":"43","author":"Noshiro","year":"1996","journal-title":"Endocrine J"},{"key":"10.1053\/clon.2001.9290_RF10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/1097-0142(19880815)62:4<686::AID-CNCR2820620407>3.0.CO;2-7","article-title":"High voltage irradiation and combination chemotherapy for malignant phaeochromocytoma","volume":"62","author":"Siddiqui","year":"1988","journal-title":"Cancer"},{"key":"10.1053\/clon.2001.9290_RF11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.7.3_Pt_2.I18","article-title":"Treatment of malignant phaeochromocytoma with combination chemotherapy","volume":"7","author":"Keiser","year":"1985","journal-title":"Hypertension"},{"key":"10.1053\/clon.2001.9290_RF12","first-page":"1039","article-title":"A case of malignant phaeochromocytoma treated with a combination of cyclophosphamide, vincristine and dacarbazine(CVD). A review of the Japanese literature of malignant phaeochromocytoma treated with a combination of CVD [Eng abstr]","volume":"70","author":"Mizuno","year":"1994","journal-title":"Nippon Naibunpi Gakkai Zasshi Folia Endocrinol Jpn"},{"key":"10.1053\/clon.2001.9290_RF13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0936-6555(97)80132-X","article-title":"Chemotherapy for neuroendocrine tumours: the Beatson Oncology Centre experience","volume":"9","author":"Hatton","year":"1997","journal-title":"Clin Oncol"},{"key":"10.1053\/clon.2001.9290_RF14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0959-8049(92)90173-Y","article-title":"Palliation of malignant phaeochromocytoma with combination chemotherapy","volume":"28","author":"Senen","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1053\/clon.2001.9290_RF15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00685513","article-title":"Case report of metastatic familial phaeochromocytoma treated with cisplatin and 5\u2013 fluorouracil","volume":"28","author":"Srimuninnimit","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/clon.2001.9290_RF16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000421-199908000-00008","article-title":"Treatment of malignant phaeochromocytomas with I-131 metaiodobenzylguanidine and chemotherapy","volume":"22","author":"Sisson","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/clon.2001.9290_RF17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000173960","article-title":"I-131 MIBG a new agent in diagnosis and treatment of phaeochromocytoma","volume":"72","author":"Shapiro","year":"1985","journal-title":"Cardiology"},{"key":"10.1053\/clon.2001.9290_RF18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/mpo.2950150405","article-title":"Update on basic research and clinical experience with metaiodobenzylguanidine","volume":"15","author":"Beierwaltes","year":"1987","journal-title":"Med Pediatr Oncol"},{"key":"10.1053\/clon.2001.9290_RF19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0959-8049(95)00511-0","article-title":"Radiolabelled MIBG in the treatment of neuroblastoma","volume":"32A","author":"Gaze","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1053\/clon.2001.9290_RF20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0167-8140(91)90080-Z","article-title":"The curability of tumours of different size by targeted radiotherapy using I-131 or Y-90","volume":"21","author":"Wheldon","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1053\/clon.2001.9290_RF21","first-page":"280","article-title":"Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma","volume":"35","author":"Lewington","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1053\/clon.2001.9290_RF22","first-page":"176","article-title":"DNA content correlation with the prognosis of phaeochromocytoma [Eng abstr]","volume":"35","author":"Yax","year":"1997","journal-title":"Chin J Surg"},{"key":"10.1053\/clon.2001.9290_RF23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1677\/joe.0.1590247","article-title":"The relative high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas","volume":"159","author":"Yoshimoto","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1053\/clon.2001.9290_RF24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<176::AID-CNCR22>3.0.CO;2-Z","article-title":"Elevated levels of telomerase activity in malignant phaeochromocytoma","volume":"82","author":"Kubota","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/clon.2001.9290_RF25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mpo.2950220607","article-title":"Hypertensive crises induced by treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine","volume":"22","author":"Wu","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"10.1053\/clon.2001.9290_RF26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/clon.1999.9072","article-title":"Management of neuroendocrine tumours","volume":"11","author":"Reed","year":"1999","journal-title":"Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655501992908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655501992908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:21:33Z","timestamp":1760541693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655501992908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0936655501992908"],"URL":"https:\/\/doi.org\/10.1053\/clon.2001.9290","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Malignant Phaeochromocytoma: A Retrospective Review of the use of MIBG and Chemotherapy in the West Midlands","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/clon.2001.9290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}